А. А. Новиков

893 total citations
143 papers, 664 citations indexed

About

А. А. Новиков is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, А. А. Новиков has authored 143 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Rheumatology, 32 papers in Radiology, Nuclear Medicine and Imaging and 28 papers in Immunology. Recurrent topics in А. А. Новиков's work include Rheumatoid Arthritis Research and Therapies (70 papers), Systemic Lupus Erythematosus Research (53 papers) and Monoclonal and Polyclonal Antibodies Research (32 papers). А. А. Новиков is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (70 papers), Systemic Lupus Erythematosus Research (53 papers) and Monoclonal and Polyclonal Antibodies Research (32 papers). А. А. Новиков collaborates with scholars based in Russia, United States and Germany. А. А. Новиков's co-authors include Е Н Александрова, Debra A. Bressan, Richard S. Maser, Gregory Dolganov, L. TOSTO, John H.J. Petrini, E L Nasonov, Д. Е. Каратеев, Т. В. Попкова and Д. С. Новикова and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular and Cellular Biology and Journal of Medicinal Chemistry.

In The Last Decade

А. А. Новиков

115 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
А. А. Новиков Russia 10 272 267 110 82 77 143 664
Shuji Nagano Japan 13 394 1.4× 118 0.4× 325 3.0× 91 1.1× 71 0.9× 42 867
Costakis Frangou United States 7 140 0.5× 165 0.6× 65 0.6× 74 0.9× 56 0.7× 7 443
Yuichiro Yabe Japan 16 193 0.7× 264 1.0× 65 0.6× 69 0.8× 73 0.9× 54 684
Estela Puchulu‐Campanella United States 13 78 0.3× 285 1.1× 79 0.7× 65 0.8× 90 1.2× 16 866
Katharine H. Dixon United States 8 304 1.1× 360 1.3× 173 1.6× 333 4.1× 84 1.1× 8 876
John Dulos Netherlands 14 63 0.2× 196 0.7× 259 2.4× 300 3.7× 65 0.8× 22 673
Florian Colbatzky Germany 12 50 0.2× 318 1.2× 53 0.5× 156 1.9× 58 0.8× 26 816
Thomas A. Zanardi United States 10 76 0.3× 286 1.1× 115 1.0× 32 0.4× 26 0.3× 13 492
Dzung T. Le United States 11 148 0.5× 278 1.0× 230 2.1× 42 0.5× 339 4.4× 15 778
Stefan Krienke Germany 10 131 0.5× 283 1.1× 426 3.9× 41 0.5× 131 1.7× 12 681

Countries citing papers authored by А. А. Новиков

Since Specialization
Citations

This map shows the geographic impact of А. А. Новиков's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. А. Новиков with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. А. Новиков more than expected).

Fields of papers citing papers by А. А. Новиков

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. А. Новиков. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. А. Новиков. The network helps show where А. А. Новиков may publish in the future.

Co-authorship network of co-authors of А. А. Новиков

This figure shows the co-authorship network connecting the top 25 collaborators of А. А. Новиков. A scholar is included among the top collaborators of А. А. Новиков based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. А. Новиков. А. А. Новиков is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Александрова, Е Н, et al.. (2023). АUTOANTIBODIES IN AUTOIMMUNE LIVER DISEASES (REVIEW OF LITERATURE). Russian Clinical Laboratory Diagnostics. 68(8). 464–474. 2 indexed citations
2.
Александрова, Е Н, et al.. (2022). Diagnostic value of screening methods for the determination of antinuclear antibodies using indirect immunofluorescence on HEp-2 cells and enzyme immunoassay in autoimmune liver diseases. Russian Clinical Laboratory Diagnostics. 67(11). 652–657. 1 indexed citations
3.
Новиков, А. А., et al.. (2022). Analysis of rheumatoid factor and acute phase proteins using microarrays in patients with rheumatoid arthritis. Russian Clinical Laboratory Diagnostics. 67(1). 43–47. 3 indexed citations
4.
Александрова, Е Н, et al.. (2019). [Clinical value of multiplex immune assay of antinuclear antibodies in systemic lupus erythematosus.]. PubMed. 63(7). 434–438. 1 indexed citations
5.
Mikhaylenko, Dmitry S., А. А. Новиков, Г. Д. Ефремов, et al.. (2017). Comparative analysis of the PCA3 gene expression in sediments and exosomes isolated from urine. Cancer Urology. 13(3). 54–60.
6.
Александрова, Е Н, et al.. (2016). CURRENT APPROACHES TO THE LABORATORY DIAGNOSIS OF RHEUMATIC DISEASES: ROLE OF MOLECULAR AND CELLULAR BIOMARKERS. SHILAP Revista de lepidopterología. 8 indexed citations
7.
Елисеев, М. С., et al.. (2016). Assessment of cardiovascular risk from the use of an interleukin-1 inhibitor in patients with severe tophaceous gout. Modern Rheumatology Journal. 10(1). 7–14. 2 indexed citations
8.
Лучихина, Е. Л., Д. Е. Каратеев, G. Lukina, et al.. (2016). POSSIBILITIES FOR PRESERVING THE RESULTS OF TREATMENT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER DOSE REDUCTION AND/OR DISCONTINUATION OF BIOLOGICAL AGENTS: A REMARCA STUDY. Modern Rheumatology Journal. 10(4). 16–20. 2 indexed citations
9.
Белов, Б. С., et al.. (2015). Assessment of clinical and immunological efficacy and safety of 23-valent pneumococcal vaccine in patients with rheumatoid arthritis. PULMONOLOGIYA. 25(6). 720–724. 1 indexed citations
10.
Александрова, Е Н, А. А. Новиков, & Е. Л. Насонов. (2015). The 2015 guidelines for the laboratory diagnosis of rheumatic diseases by the All-Russian Public Organization «Association of Rheumatology of Russia». SHILAP Revista de lepidopterología. 9(4). 25–36. 5 indexed citations
11.
Александрова, Е Н, et al.. (2014). Иммунологические предикторы эффекта анти-В-клеточной терапии при ревматоидном артрите. 59(3). 1 indexed citations
12.
Авдеева, А. С., А. А. Новиков, Е Н Александрова, et al.. (2014). CHANGES OF CYTOKINE LEVELS DURING THERAPY WITH METHOTREXATE AND ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (REMARCA STUDY). SHILAP Revista de lepidopterología. 1 indexed citations
13.
14.
Новикова, Д. С., Т. В. Попкова, Е. В. Герасимова, et al.. (2014). CHANGES IN HEART RATE, HEART RATE VARIABILITY AND QT INTERVAL IN WOMEN WITH RHEUMATOID ARTHRITIS DURING RITUXIMAB TREATMENT. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Новиков, А. А., et al.. (2014). Role of laboratory biomarkers in monitoring and prediction of the effectiveness of treatment of rheumatic diseases using genetically engineered drugs. Modern Rheumatology Journal. 0(1). 5–5. 4 indexed citations
16.
Насонов, Е. Л., Е Н Александрова, & А. А. Новиков. (2014). [Systemic autoimmune rheumatic diseases in 2013: problems of laboratory diagnosis].. SHILAP Revista de lepidopterología. 86(5). 4–9. 2 indexed citations
17.
Новикова, Д. С., et al.. (2009). [Clinical significance of the assessment of cardiac rhythm variability in patients with rheumatoid arthritis].. PubMed. 87(1). 27–32. 2 indexed citations
18.
Попкова, Т. В., Е Н Александрова, Д. С. Новикова, et al.. (2008). Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection. SHILAP Revista de lepidopterología. 3 indexed citations
19.
Каратеев, Д. Е., et al.. (2008). [Early diagnosis of rheumatoid arthritis in modern clinical practice (results of a follow-up of a Moscow cohort of early arthritis patients participating in the program RADICAL)].. PubMed. 80(5). 8–13. 3 indexed citations
20.
Reshetnyak, Т. М., et al.. (2005). Lung Pathology in Antiphospholipid Syndrome. General Reanimatology. 1(5). 34–34. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuji Nagano Breakdown of academic impact, for papers by Costakis Frangou Breakdown of academic impact, for papers by Yuichiro Yabe Breakdown of academic impact, for papers by Estela Puchulu‐Campanella Breakdown of academic impact, for papers by Katharine H. Dixon Breakdown of academic impact, for papers by John Dulos Breakdown of academic impact, for papers by Florian Colbatzky Breakdown of academic impact, for papers by Thomas A. Zanardi Breakdown of academic impact, for papers by Dzung T. Le Breakdown of academic impact, for papers by Stefan Krienke
Rankless by CCL
2026